CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Hydroxychloroquine prophylaxis - vintage wine for every new bottle?

Author: 
Dr. Mangala Sonavani Borkar, Dr. Shailaja V Rao, Dr. Zeba Firdous Shaikh, Dr. Mahesh Shrikrishna Patil, Dr. Ashish Rajan and Dr. Shruti Shreyas Karnik
Subject Area: 
Health Sciences
Abstract: 

Chloroquine and Hydroxychloroquine have been in use for more than 75 years with a satisfactory safety profile, for malaria and autoimmune disorders. They have been repositioned for the prophylaxis or treatment of emerging viral disorders like SARS Co-V, MERS and now in SARS-CoV2, which ,in a few months, has caused havoc globally. Drugs used in earlier epidemics are being tried again and HCQ is in the forefront for its anti-viral and immune modulatory properties. It has shown good results in vitro and few observational studies, but there are objections that it has not been proved in randomised control trials, which was difficult in the initial pandemonium .However, more than 150 trials have now been registered and the picture will be clearer. HCQ has stood the test of the controversies and must be the most trending molecule currently-whether the fanfare from the President of America or it’s temporary suspension and re-inclusion in the WHO Solidarity trial! The apex body of India, ICMR, has stood by it through thick and thin and has expanded its advisory for the prophylactic use of HCQ in SARS-CoV2.It has also started a trial for evaluating its use in prophylaxis. Most of the reports so far are related to its therapeutic utility, but the doses used globally are variable. This article reviews the profile of HCQ and its status in preventing infection or severity of SARS-CoV2 and focuses on its prophylactic role.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran